Avacta Group Plc (AVCTF)
OTCMKTS · Delayed Price · Currency is USD
0.7899
0.00 (0.00%)
At close: Feb 11, 2026
Avacta Group Employees
Avacta Group had 151 employees as of December 31, 2024. The number of employees decreased by 3 or -1.95% compared to the previous year.
Employees
151
Change (1Y)
-3
Growth (1Y)
-1.95%
Revenue / Employee
$1,025
Profits / Employee
-$568,018
Market Cap
355.09M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 151 | -3 | -1.95% |
| Dec 31, 2023 | 154 | 34 | 28.33% |
| Dec 31, 2022 | 120 | -13 | -9.77% |
| Dec 31, 2021 | 133 | 10 | 8.13% |
| Dec 31, 2020 | 123 | 4 | 3.36% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Silence Therapeutics | 116 |
| Vaxart | 105 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
| Nuo Therapeutics | 9 |
| ZIVO Bioscience | 7 |
| Vicapsys Life Sciences | 2 |
Avacta Group News
- 2 months ago - Avacta Group Plc (AVCTF) Discusses Initial Faridoxorubicin Phase Ib Data and Safety Profile in Salivary Gland Cancer Transcript - Seeking Alpha
- 3 months ago - Full Year 2024 Avacta Group PLC Live Presentation Transcript - GuruFocus
- 4 months ago - Avacta (AIM) Reports Promising Results in Faridoxorubicin Clinical Trial - GuruFocus
- 4 months ago - Half Year 2025 Avacta Group PLC Live Presentation Transcript - GuruFocus
- 4 months ago - Avacta Group Plc (AVCTF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Avacta Group Plc 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 4 months ago - Avacta Group (AVCTF) Reports Flat Revenue in First-Half Earnings - GuruFocus
- 4 months ago - Avacta Group Plc GAAP EPS of 4.46p, revenue of £0.06M - Seeking Alpha